Bioelectronics Corp (BIEL)

[srinsocal]

The argument that the ActiPatch is not effective at accelerating soft tissue healing would mean that the FDA was negligent in 2002 when it approved the ActiBand, the previous name of the ActiPatch, for use in the treatment of edema following Blepharoplasty (eyelid surgery).

Is this your argument, that the FDA was negligent in 2002 and approved a scam device? The ActiBand is the same device as the current ActiPatch which can still be prescribed for use after
Blepharoplasty as an FDA approved device.


http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K022404